Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Manns

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Infectious Diseases|August 1, 1994
Demonstration of human T lymphotropic virus type I (HTLV-I)-specific T cell responses from seronegative and polymerase chain reaction-negative persons exposed to HTLV-IM Nishimura, A G Kermode, M Clerici, et al.
International Journal of Cancer|March 29, 1995
Human T-cell lymphotropic virus type I and severe neoplasia of the cervix in JamaicaH D Strickler, C Rattray, C Escoffery, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1996
Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphomaR M Giusti, E M Maloney, B Hanchard, et al.
American Journal of Epidemiology|December 1, 1995
Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in JamaicaA Krämer, E M Maloney, O S Morgan, et al.
AIDS Research and Human Retroviruses|June 1, 1993
The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West AfricaR J Biggar, J E Neequaye, A R Neequaye, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 1992
Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriersZ N Berneman, R B Gartenhaus, M S Reitz, et al.
Annals of Internal Medicine|February 1, 1989
T-cell lymphoma, tropical spastic paraparesis, and malignant fibrous histiocytoma in a patient with human T-cell lymphotropic virus, type 1J W Lee, E P Fox, P Rodgers-Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapyC L Tendler, S J Greenberg, W A Blattner, et al.
International Journal of Cancer|February 6, 1999
HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer ratesH D Strickler, G D Kirk, J P Figueroa, et al.
American Journal of Medical Genetics|January 2, 1996
HLA DRB1*DQB1* haplotype in HTLV-I-associated familial infective dermatitis may predict development of HTLV-I-associated myelopathy/tropical spastic paraparesisL LaGrenade, S Sonoda, W Miller, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Infectious Diseases|August 1, 1994
Demonstration of human T lymphotropic virus type I (HTLV-I)-specific T cell responses from seronegative and polymerase chain reaction-negative persons exposed to HTLV-IM Nishimura, A G Kermode, M Clerici, et al.
International Journal of Cancer|March 29, 1995
Human T-cell lymphotropic virus type I and severe neoplasia of the cervix in JamaicaH D Strickler, C Rattray, C Escoffery, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1996
Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphomaR M Giusti, E M Maloney, B Hanchard, et al.
American Journal of Epidemiology|December 1, 1995
Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in JamaicaA Krämer, E M Maloney, O S Morgan, et al.
AIDS Research and Human Retroviruses|June 1, 1993
The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West AfricaR J Biggar, J E Neequaye, A R Neequaye, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 1992
Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriersZ N Berneman, R B Gartenhaus, M S Reitz, et al.
Annals of Internal Medicine|February 1, 1989
T-cell lymphoma, tropical spastic paraparesis, and malignant fibrous histiocytoma in a patient with human T-cell lymphotropic virus, type 1J W Lee, E P Fox, P Rodgers-Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapyC L Tendler, S J Greenberg, W A Blattner, et al.
International Journal of Cancer|February 6, 1999
HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer ratesH D Strickler, G D Kirk, J P Figueroa, et al.
American Journal of Medical Genetics|January 2, 1996
HLA DRB1*DQB1* haplotype in HTLV-I-associated familial infective dermatitis may predict development of HTLV-I-associated myelopathy/tropical spastic paraparesisL LaGrenade, S Sonoda, W Miller, et al.
Pageof 11